The science of selective estrogen receptor modulators: concept to clinical practice.
Jordan
V Craig
VC
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111-2497, USA. v.craig.jordan@fccc.edu
D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000494:pharmacology / Q000627:therapeutic use*; D011960:Receptors, Estrogen / Q000187:drug effects; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use*
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride